8-K: TILT Partners MariMed for PA Cannabis Expansion

TILT Holdings' subsidiary, Standard Farms, enters a four-year management services agreement with MariMed Advisors to enhance its Pennsylvania medical marijuana operations and distribute MariMed brands.

Summary

• Standard Farms, LLC, a wholly owned subsidiary of TILT Holdings Inc., entered into a Management Services Agreement (MSA) with MariMed Advisors, Inc., a wholly owned subsidiary of MariMed Inc., on July 30, 2025.
• Under the MSA, MariMed Advisors will provide comprehensive management services for Standard Farms' medical marijuana cultivation and processing operations in Pennsylvania, while Standard Farms remains the permit holder.
• Services include oversight of budgeting, financial planning, compliance, quality management, accounting, bank account management, and tax and licensing requirements.
• MariMed will receive a management fee of 12.5% of Standard Farms' gross revenue, payable monthly, with provisions for deferring payment if necessary.
• The MSA has an initial term of four years, commencing September 1, 2025, with automatic renewals.
• Standard Farms intends to produce and distribute MariMed's award-winning brands, including Betty's Eddies, Bubby's Baked, Vibations, InHouse, and Nature's Heritage, in Pennsylvania.
• The agreement explicitly states that it does not grant MariMed ownership or any beneficial interest in Standard Farms or its permit, maintaining MariMed's status as an independent contractor.

Sentiment

Score: 8

Explanation: The filing announces a significant strategic partnership that is mutually beneficial, expanding market reach for MariMed and enhancing operations for TILT. Management comments are highly positive, and the agreement positions both companies for growth in a key cannabis market.

Positives

• MariMed gains entry into the Pennsylvania medical marijuana market, the fifth most populous state, aligning with its 'Expand the Brand' strategy.
• TILT's Standard Farms operations will benefit from MariMed's unique and expert experience in marketing and growing medical marijuana.
• The partnership is expected to bring MariMed's trusted and high-quality branded products to medical marijuana patients in Pennsylvania, which have a strong track record in other markets.
• TILT views this partnership as a positive step forward in its ongoing strategic review process.
• The agreement provides a new revenue stream for MariMed through the 12.5% management fee on gross revenue.

Risks

• Reductions in customer spending could impact revenue and profitability.
• Ability to recruit and retain key personnel is crucial for operational success.
• Disruptions from the integration efforts of acquired companies could affect performance.
• Changes in demand for the Company's services and products may occur.
• Changes in law and its enforcement, particularly regarding marijuana, pose regulatory risks.
• Changes in the economic environment could negatively affect business operations.
• Potential legal actions by governmental bodies contesting the right to grow, sell, manufacture, or process medical marijuana could prohibit legal operation of the business.

Future Outlook

MariMed aims to expand its brand distribution into new, high-growth markets, viewing Pennsylvania as a strong medical marijuana market likely to transition to adult-use. TILT anticipates similar success for MariMed's brands in Pennsylvania as seen in other markets and considers this partnership a positive step in its strategic review process.

Management Comments

• Jon Levine, MariMed's Chief Executive Officer, stated: "We are thrilled to bring our brands to consumers in the great state of Pennsylvania, a strong medical marijuana market that is likely to become the next cannabis adult-use market. These agreements align with our Expand the Brand strategy, a top priority initiative that is driving us toward becoming the leading consumer packaged goods company in medical marijuana. We will continue to identify opportunities to expand the distribution of our brands into new, high-growth markets and deeper in our existing markets."
• Tim Conder, TILT's Chief Executive Officer, commented: "We are excited to partner with the MariMed team and to support their expansion. We are eager to work closely with MariMed through this MSA agreement, providing their trusted and high-quality branded products to medical marijuana patients throughout Pennsylvania. These brands lead in other markets, and we expect similar success here. Our team has done a tremendous job building a foundation of quality and trust with patients under the Standard Farms banner, and we expect this foundation to be the right launching pad for MariMed. We view this partnership as another positive step forward in the strategic review process we have been conducting over the past few quarters."

Industry Context

This strategic partnership reflects a growing trend in the U.S. cannabis industry where multi-state operators (MSOs) like MariMed expand their brand footprint into new markets through management services agreements or licensing deals, especially in states with strict regulatory frameworks that may limit direct ownership. This approach allows companies to leverage existing infrastructure and permits while introducing established brands, positioning for potential adult-use market transitions.

Comparison to Industry Standards

• Management Services Agreements (MSAs) are a common and established mechanism in the highly regulated U.S. cannabis industry, particularly in states like Pennsylvania where direct out-of-state ownership or control of licensed entities may be restricted.
• The 12.5% management fee is within the typical range for such agreements in the cannabis sector, reflecting compensation for comprehensive operational and strategic oversight.
• The strategy of leveraging established brands (MariMed's portfolio) through a local permit holder (TILT's Standard Farms) is a widely adopted model for market entry and expansion by leading cannabis consumer packaged goods companies.

Stakeholder Impact

• Shareholders: Potential for increased revenue, market share, and strategic growth for both TILT and MariMed.
• Employees: Business Employees of Standard Farms will work under the direction and control of MariMed's management services.
• Customers: Medical marijuana patients in Pennsylvania will gain access to MariMed's portfolio of award-winning cannabis brands.
• Regulatory Authorities: The agreement and affiliation of Jon Levine as Manager/Operator will be submitted to the Pennsylvania Bureau of Medical Marijuana for approval and ongoing compliance.

Next Steps

• MariMed will assume day-to-day management of TILT's Standard Farms cultivation and processing facility in White Haven, Pennsylvania, effective September 1, 2025.
• Standard Farms intends to produce and distribute MariMed's award-winning brands in Pennsylvania.
• The parties will cooperate in defending any legal action contesting the right to grow, sell, manufacture, or process medical marijuana, and appealing any judgment.

Key Dates

Recommendation

This strategic partnership is a strong positive for both TILT and MariMed. For TILT, it brings proven management expertise and established brands to its Pennsylvania operations, potentially boosting performance and market share. For MariMed, it represents a significant expansion into a key state, aligning with its growth strategy and opening a new revenue stream. The cannabis market in Pennsylvania has strong growth potential, especially with the likelihood of adult-use legalization. This collaboration enhances the competitive position of both companies, making it an attractive investment opportunity.

Keywords

Cannabis, Medical Marijuana, Pennsylvania, Management Services Agreement, TILT Holdings, MariMed, Standard Farms, Cultivation, Processing, Brand Expansion, Strategic Partnership, Cannabis Brands